Takanobu Shigeta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takanobu Shigeta has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
N. Matsuno
9 shared publicationsS. Enosawa
8 shared publicationsM. Kasahara
Transplantation, National Children’s Hospital, Tokyo, Japan
7 shared publicationsH. Mizunuma
6 shared publicationsH. Obara
Tokyo Metropolitan University, Mechanical Engineering, Tokyo, Japan
5 shared publicationsS. Sakamoto
Transplantation, National Children’s Hospital, Tokyo, Japan
5 shared publications
Latest Publications
- 14 October 2014
- Published by Wiley in Pediatric Transplantation
- Vol. 18 (8) , 860-867
Basiliximab treatment for steroid‐resistant rejection in pediatric patients following liver transplantation for acute liver failure
An IL‐2 receptor antagonist, basiliximab, decreases the frequency of ACR in liver transplant (LT) recipients as induction therapy. The aim of this study was to evaluate the effectiveness of basiliximab against SRR as rescue therapy in pediatric LT patients with ALF. Forty pediatric ALF patients underwent LT between November 2005 and July 2013. Among them, seven patients suffering from SRR were enrolled in this study. The median age at LT was 10 months (6–12 months). SRR was defined as the occurrence of refractory rejection after more than two courses of steroid pulse therapy. Basiliximab was administered to all patients. The withdrawal of steroids without deterioration of the liver function was achieved in six patients treated with basiliximab therapy without patient mortality, although one patient developed graft loss and required retransplantation for veno‐occlusive disease. The pathological examinations of liver biopsies in the patients suffering from SRR revealed severe centrilobular injuries, particularly fibrosis within one month after LT. We demonstrated the effectiveness and safety of rescue therapy consisting of basiliximab for SRR in pediatric LT recipients with ALF.
- 14 October 2014
- Published by Wiley in Pediatric Transplantation
- Vol. 18 (8) , 860-867
Basiliximab treatment for steroid‐resistant rejection in pediatric patients following liver transplantation for acute liver failure
An IL‐2 receptor antagonist, basiliximab, decreases the frequency of ACR in liver transplant (LT) recipients as induction therapy. The aim of this study was to evaluate the effectiveness of basiliximab against SRR as rescue therapy in pediatric LT patients with ALF. Forty pediatric ALF patients underwent LT between November 2005 and July 2013. Among them, seven patients suffering from SRR were enrolled in this study. The median age at LT was 10 months (6–12 months). SRR was defined as the occurrence of refractory rejection after more than two courses of steroid pulse therapy. Basiliximab was administered to all patients. The withdrawal of steroids without deterioration of the liver function was achieved in six patients treated with basiliximab therapy without patient mortality, although one patient developed graft loss and required retransplantation for veno‐occlusive disease. The pathological examinations of liver biopsies in the patients suffering from SRR revealed severe centrilobular injuries, particularly fibrosis within one month after LT. We demonstrated the effectiveness and safety of rescue therapy consisting of basiliximab for SRR in pediatric LT recipients with ALF.
- 1 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98, 171-172
The Outcomes of Living Donor Liver Transplantation Receiving Reduced Left Lateral Segmental Grafts.
- 1 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98, 171-172
The Outcomes of Living Donor Liver Transplantation Receiving Reduced Left Lateral Segmental Grafts.
- 1 June 2013
- Published by Elsevier in Transplantation Proceedings
- Vol. 45 (5) , 1808-1810
Transgenic Pig Expressing the Red Fluorescent Protein Kusabira-Orange as a Novel Tool for Preclinical Studies on Hepatocyte Transplantation
- 1 June 2013
- Published by Elsevier in Transplantation Proceedings
- Vol. 45 (5) , 1808-1810
Transgenic Pig Expressing the Red Fluorescent Protein Kusabira-Orange as a Novel Tool for Preclinical Studies on Hepatocyte Transplantation
- 1 June 2013
- Published by Elsevier in Transplantation Proceedings
- Vol. 45 (5) , 1690-1692
Temperature Controlled Machine Perfusion System for Liver
- 1 June 2013
- Published by Elsevier in Transplantation Proceedings
- Vol. 45 (5) , 1690-1692
Temperature Controlled Machine Perfusion System for Liver
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 303
Temperature Controlled Machine Perfusion System for Liver
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 303
Temperature Controlled Machine Perfusion System for Liver
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 652
Temperature Controlled Machine Perfusion System for Liver
- 27 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 652
Temperature Controlled Machine Perfusion System for Liver
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 527
Usefulness of Continuous Machine Perfusion Preservation with Rewarming Method for Donation after Cardiac Death Liver Graft
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 527
Usefulness of Continuous Machine Perfusion Preservation with Rewarming Method for Donation after Cardiac Death Liver Graft
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 209
Usefulness of Continuous Machine Perfusion Preservation with Rewarming Method for Donation after Cardiac Death Liver Graft
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 209
Usefulness of Continuous Machine Perfusion Preservation with Rewarming Method for Donation after Cardiac Death Liver Graft
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 285
Transgenic Pig Expressing Red Fluorescent Protein, Kusabila-Orange as a Novel Tool for Preclinical Research of Hepatocyte Transplantation
- 1 November 2012
- Published by Wolters Kluwer Health in Transplantation
- Vol. 94 (10S) , 285
Transgenic Pig Expressing Red Fluorescent Protein, Kusabila-Orange as a Novel Tool for Preclinical Research of Hepatocyte Transplantation
- 4 June 2012
- Published by Wiley in Pediatric Transplantation
- Vol. 16 (5) , 496-500
Diaphragmatic hernia in infants following living donor liver transplantation: Report of three cases and a review of the literature
Shigeta T, Sakamoto S, Kanazawa H, Fukuda A, Kakiuchi T, Karaki C, Uchida H, Matsuno N, Tanaka H, Kasahara M. Diaphragmatic hernia in infants following living donor liver transplantation: Report of three cases and a review of the literature.Abstract: DH is a rare complication following LT. This report presents three cases of right‐sided DH after LT using a left‐sided graft. All of the patients were younger than one yr of age, and they were critically ill owing to their original disease, characterized by biliary atresia, progressive familiar intrahepatic cholestasis, and acute liver failure. DH occurred with sudden onset within three months after LT. All of the cases were promptly diagnosed and treated. A literature review of 24 cases of DH identified four factors associated with DH: left‐sided graft, right‐sided DH, relatively delayed onset of DH, and age‐specific chief complaint. DH following LT should be considered as a potential surgical complication when a left‐sided graft is used, especially in small infants with coagulopathy and malnutrition.
- 4 June 2012
- Published by Wiley in Pediatric Transplantation
- Vol. 16 (5) , 496-500
Diaphragmatic hernia in infants following living donor liver transplantation: Report of three cases and a review of the literature
Shigeta T, Sakamoto S, Kanazawa H, Fukuda A, Kakiuchi T, Karaki C, Uchida H, Matsuno N, Tanaka H, Kasahara M. Diaphragmatic hernia in infants following living donor liver transplantation: Report of three cases and a review of the literature.Abstract: DH is a rare complication following LT. This report presents three cases of right‐sided DH after LT using a left‐sided graft. All of the patients were younger than one yr of age, and they were critically ill owing to their original disease, characterized by biliary atresia, progressive familiar intrahepatic cholestasis, and acute liver failure. DH occurred with sudden onset within three months after LT. All of the cases were promptly diagnosed and treated. A literature review of 24 cases of DH identified four factors associated with DH: left‐sided graft, right‐sided DH, relatively delayed onset of DH, and age‐specific chief complaint. DH following LT should be considered as a potential surgical complication when a left‐sided graft is used, especially in small infants with coagulopathy and malnutrition.